A Flaming Hot Stock Tip (Straight from My Spam Folder)
I received an email about a month ago that I felt would be selfish–no, downright immoral–of me not to share. When a message with the subject “FDA approval is about to send this stock up fifty fold” comes through my inbox (OK, spam box), how could I ignore such a hot stock tip. I knew I had to investigate further!
Now, I know what you are thinking..
“How the hell did such an important email get sent to Spam?”
I agree! I will need to inquire with Google on how they could prevent me from quickly seeing such important information. Probably trying to keep this hot stock tip for themselves…
You are probably also wondering who I know that has access to such info. Well, it was complete stranger, Elton Guerrero!
This good Samaritan, who clearly has nothing to gain and everything to lose by passing on his insider information to me, has risked a great deal to get me this message. It is in Elton’s honor that I share his message with you!
The email, in it’s entirety is below (emphasis is my own):
Why is Quest Management (Symbol: QSMG) guaranteed to jump 5,000% this month?
They have the cure for cancer.
This biotech is run by some of the most prolific scientists in America. Together, they have more than 400 years of experience in the field and have more diplomas than we can even imagine.
Cancers kills 1 out of 4 people in our country and we have all been affected by it either directly or indirectly.
Who doesn’t know someone who’s died from it?
The company’s scientists are targeting cancer using stem cells. They are able to identify the bad cells and destroy them without radiating the entire body (like is common with chemo).
Apart from saving millions of lives, their treatment will surely become the Number 1 selling drug on earth.
The company has already made serious headway thanks to nearly two decades of research.
This cutting edge biotech company has completed animal trials successfully and just wrapped up FDA-approved human trials last week.
The next step is the public announcement of those results, which we hear through the grapevine have beat all expectations and will change the world of medicine forever.
The results will be announced this month, and once they are out, the stock will jump to $25 a share overnight and will continue up to $50 or more quickly after.
“Quest”‘s biotech arm could have a cancer cure that can be totally effective in killing tumors in more than 40% of patients worldwide available in hospitals throughout the globe by the end of the year.
Once that happens, we’re talking about a $1000 a share stock.
We’re literally coming in at the last mile, out of no where, and grabbing profits from their last 2 decades of hard work.
Consider buying QSMG right now while it’s still at under 5 dollars and make sure to tell all your friends to do the same before the price explodes.
Wow. Riveting stuff! And a stock that is guaranteed to go from under $5 to $25 to $50 to $1000 to $1 M a share like that! Sign me up!
I’m not one to look a gift horse in the mouth, or to question the validity of unsolicited stock tips that Google deems to be Spam-worthy, but for the sake of this writing, I thought I would do my homework.
Who the hell is Quest Management?
My first real question was how have I never heard of this company?
This motley crew of rag tag geniuses with an unfathomable number of diplomas that are just out there curing cancer known as Quest Management. Perhaps they have just been flying under the radar, diligently working in the shadows for the last two decades.
According to their profile on Yahoo! Finance, “Quest Management Inc. distributes fitness equipment to wholesale markets in the United States. Its product line includes sports equipment, gym equipment, exercise equipment, and bodybuilding equipment. The company was founded in 2014 and is based in Malta, Latvia.”
Fitting 20 years of work into 3 years of existence sounds too good to be true! Also, they managed to find a cure for cancer while distributing exercise equipment. Talk about a pivot!
Well, actually they did sign a letter of intent to purchase a biotech company based in Los Angeles called Stemvax that is working on cancer research. Note that Stemvax has only been around since 2014 as well.
Mind blown again.
And who is that captain at the helm of this miracle ship? Why it’s 37 year old CEO, President, Treasurer, Secretary, Director, and likely James Bond villain, Dmitrij Ozolins (Source: Google Finance). I can’t imagine how many diplomas he must have!
Can I research their website? Yes. Sort of. Their website is like ground zero for bad stock photography and incomprehensible business jargon.
In their own words, “At Quest Management Inc., our mission is simple: Significant returns from diversified companies that have real, sustainable demand for their products and services.”
I read through their entire website and honestly have not even a guess at what they do besides business things. If that doesn’t inspire confidence in this investment, nothing will.
If they are a public company, there must be financial reports? Sure thing! You can see their latest quarterly filing here. They’ve made literally hundreds of dollars.
That’s just more room to grow!
Additional Fact Checks
There seem to be some inconsistencies in this hot stock tip’s information about Quest and what all of the internet is reporting. Probably nothing to worry about.
Any other factual errors in the email?
Elton mentions that “Cancer kills 1 out of 4 people in our country” early on in the email. According to the National Cancer Institute, “The number of cancer deaths (cancer mortality) is 171.2 per 100,000 men and women per year (based on 2008-2012 deaths).” Ok, so more like 1 out 588 people, but who’s counting?
But Elton does seem to know at least a thing or two about cancer and medicine. This wonder treatment works “without radiating the entire body (like is common with chemo).” Last time I checked radiation therapy was not the same as chemotherapy. Look, I learned something new.
Not really a fact, but who is the “we” and the “grapevine” that is cryptically referenced? Given the lack of supporting facts on this one, I am forced to assume it’s some prestigious and reputable investment firm. Points for Elton.
And those FDA trials that this entire investment thesis basically hinges on? Much to my surprise, after a search of FDA clinical trial records, nothing relating to Quest or Stemvax and stem cell cancer treatments could be found. Erroneous!
Overlooking some minor and/or gaping holes in the materials presented, we have the major benefit of hindsight on our side. As mentioned, I received this email in early April, and it’s now early May. If you made it this far, I’m sure you are waiting in anxious anticipation of how much money I could have made if I invested.
This fifty fold stock.
This undiscovered hidden gem.
This golden goose and purveyor of the future number 1 selling drug on earth.
This hot stock tip to end all stock tips.
Not only did Quest Management not jump 50 fold or even double, it’s down 88% to 22 cents per share!
According to this article from Insider Financial, a possibly reputable source, the decline was due to the OTC exchange hitting QSMG with a sanction known as Caveat Emptor, which means they were engaged in one of the following:
- Promotion/Spam without Adequate Current Information
- Investigation of Fraud or Other Criminal Activities
- Unsolicited Quotes
- Other Public Interest Concern
I too share in your disappointment with how this all ended. We were on this journey to unspeakable riches together, and reality just pulled the rug out from underneath us.
If there is a lesson to be learned here, it’s that the stock market is highly unpredictable, and even a sure thing like QSMG can go awry.
We’ll get ’em next time Elton! Keep those hot stock tips coming!
Latest posts by Sean S (see all)
- Why the First Business You Start Should be an Investment Club - May 22, 2018
- What are Some of the Coolest Things you can Buy Using Bitcoin? - May 18, 2018
- Evaluating a Cryptocurrency Investment Opportunity - April 27, 2018